Pfizer Acquires Seagen
have announced that they have entered into a definitive merger agreement under which Pfizer will acquire Seagen, a pioneer in antibody drug conjugate technology is called ADC, which is rapidly emerging as a powerful tool in cancer treatment.
Company Overview – Seagen
Company Overview – Pfizer
No of Pages: 79
To view another Acquisition report click here
Follow our LinkedIn page for more updates